People · Operator
Named in public records as an officer, director or promoter · active 2012–2022 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pursuit Vascular, Inc. | — | Other Health Care | Series A | $12.3M | $42.1M | 2012 |
| Stratix Labs Corp | — | Biotechnology | Pre-Seed | $1.3M | $9.8M | 2022 |
Robert Ziebol at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Ziebol on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin Roche | 1 | 6 |
| Mark Marlow | 1 | 4 |
| Dale Spencer | 1 | 3 |
| Jack Helms | 1 | 2 |
| Robert Weinmann, M.D. | 1 | 1 |
| Roy Martin, Jr. | 1 | 1 |
| Josh Erickson | 1 | 1 |
| Mary Jo Baarsch | 1 | 1 |
| Mark Mulvahill | 1 | 1 |
| Doug Killion | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.